open access

Vol 78, No 3 (2010)
REVIEWS
Published online: 2010-05-11
Submitted: 2013-02-22
Get Citation

Efficacy and safety of indacaterol - new long-acting β2 agonist

Ryszarda Chazan
Pneumonol Alergol Pol 2010;78(3):229-235.

open access

Vol 78, No 3 (2010)
REVIEWS
Published online: 2010-05-11
Submitted: 2013-02-22

Abstract

Combination of ICS and LABA for asthmatics and several classes of long-acting bronchodilator drugs for COPD patients are recommended. Long-acting bronchodilator therapy should be always considered when patients are symptomatic.
Incorporation of once daily dose administration is an important strategy to improve adherence and is the method preferred by most patients. Several trials evaluated the efficacy and safety of indacaterol in patients with asthma and COPD. The results of the study suggested that indacaterol has a wide therapeutic index and is safe and well tolerated.

Abstract

Combination of ICS and LABA for asthmatics and several classes of long-acting bronchodilator drugs for COPD patients are recommended. Long-acting bronchodilator therapy should be always considered when patients are symptomatic.
Incorporation of once daily dose administration is an important strategy to improve adherence and is the method preferred by most patients. Several trials evaluated the efficacy and safety of indacaterol in patients with asthma and COPD. The results of the study suggested that indacaterol has a wide therapeutic index and is safe and well tolerated.
Get Citation

Keywords

bronchodilators; chronic obstructive pulmonary disease; asthma; indacaterol

About this article
Title

Efficacy and safety of indacaterol - new long-acting β2 agonist

Journal

Advances in Respiratory Medicine

Issue

Vol 78, No 3 (2010)

Pages

229-235

Published online

2010-05-11

Bibliographic record

Pneumonol Alergol Pol 2010;78(3):229-235.

Keywords

bronchodilators
chronic obstructive pulmonary disease
asthma
indacaterol

Authors

Ryszarda Chazan

Important: This website uses cookies.tanya dokter More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Czasopismo Pneumonologia i Alergologia Polska dostęne jest również w Ikamed - księgarnia medyczna

Wydawcą serwisu jest "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl